FDA NDC Directory · JSON-LD · Markdown

Terbinafine

NDC 69097-859 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerCipla USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA077533
Dosage form / routeTABLET · ORAL
Active ingredientsTERBINAFINE HYDROCHLORIDE (250 mg/1)
Marketing started20160627
Package count3

External sources

Source: openFDA. Public-domain (CC0).